aTyr Pharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
/ 
Others were interested in
See all stocksFrequently asked questions
To buy aTyr Pharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for aTyr Pharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for aTyr Pharma Inc. is ATYR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
aTyr Pharma Inc. has its primary listing on NASDAQ. You can trade aTyr Pharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, aTyr Pharma Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include aTyr Pharma Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like aTyr Pharma Inc. or others.